IL-13 Antikörper

Produktnummer ABIN6963882

Der Ratte Monoklonal Anti-IL-13-Antikörper wurde für ELISA validiert. Er ist geeignet, IL-13 in Proben von Human zu detektieren. Es sind 5+ Publikationen verfügbar.

Kurzübersicht für IL-13 Antikörper (ABIN6963882)

Target: IL-13 (IL13) (Interleukin 13 (IL13))

Reaktivität: Human

Wirt: Ratte

Klonalität: Monoklonal

Konjugat: Dieser IL-13 Antikörper ist unkonjugiert

Applikation: ELISA

Klon: 25K2

Produktdetails anti-IL-13 Antikörper

Spezifität: Native and recombinant IL-13

Produktmerkmale: This monoclonal antibody enables specific detection of human IL-13 in ELISA. Serum/Plasma samples

Aufreinigung: Purified from in vitro cultures by protein G affinity chromatography.

Sterilität: 0.2 μm filtered

Immunogen: Recombinant human IL-13

Isotyp: IgG1

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Kommentare:

ABIN6963882, ABIN7489147, ABIN6963883 and ABIN7489148 is recommended as capture mAb in ELISA in combination with detection mAb ABIN6963880, ABIN7489145, ABIN6963881 and ABIN7489146 .

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: supplied at 0.5 mg/mL in PBS with 0.02 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/ thawing.

Haltbarkeit: 18 months

Referenzen für anti-IL-13 Antikörper (ABIN6963882)

Kordulewska, Cieślińska, Fiedorowicz, Jarmołowska, Piskorz-Ogórek, Kostyra: "Cytokines concentrations in serum samples from allergic children-Multiple analysis to define biomarkers for better diagnosis of allergic inflammatory process." in: Immunobiology, Vol. 223, Issue 11, pp. 648-657, (2019) (PubMed).

Kordulewska, Kostyra, Cieślińska, Fiedorowicz, Jarmołowska: "Cytokine production by PBMC and serum from allergic and non-allergic subjects following in vitro histamine stimulation to test fexofenadine and osthole anti-allergic properties." in: European journal of pharmacology, Vol. 791, pp. 763-772, (2017) (PubMed).

Camarca, Gianfrani, Ariemma, Cimmino, Bruzzese, Scerbo, Picascia, DEsposito, Beguinot, Formisano, Valentino: "Human Peripheral Blood Mononuclear Cell Function and Dendritic Cell Differentiation Are Affected by Bisphenol-A Exposure." in: PLoS ONE, Vol. 11, Issue 8, pp. e0161122, (2017) (PubMed).

Shastri, Stewart, Eapen, Peterson, Zaidi, Gueven, Sohal, Patel: "Opposing effects of low molecular weight heparins on the release of inflammatory cytokines from peripheral blood mononuclear cells of asthmatics." in: PLoS ONE, Vol. 10, Issue 3, pp. e0118798, (2015) (PubMed).

Di Lullo, Marcatti, Heltai, Brunetto, Tresoldi, Bondanza, Bonini, Ponzoni, Tonon, Ciceri, Bordignon, Protti: "Th22 cells increase in poor prognosis multiple myeloma and promote tumor cell growth and survival." in: Oncoimmunology, Vol. 4, Issue 5, pp. e1005460, (2015) (PubMed).

Details zu IL-13

Target: IL-13 (IL13) (Interleukin 13 (IL13))

Andere Bezeichnung: IL13

Gen-ID: 3596

Pathways: JAK-STAT Signalweg, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Proton Transport